Purchase Order 75N95019P00625

Award Date 9/10/19
Potential Completion Date 1/31/20
Potential Value $249K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Molecular Devices LLC for an on-site service agreement for an OCTET RED96 instrument. The potential value of the contract is $9,869.50, and the period of performance ends on December 2, 2022. The contract was awarded on July 26, 2019 and does not have a set-aside designation. Molecular Devices LLC is a for-profit...
This is a firm-fixed-price purchase order for $21,820.00 awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Molecular Devices LLC, a division of Danaher Corporation. The award is for the provision of consumables for the Octet instrument, which is used in life science research, pharmaceutical, and biotherapeutic development. Molecular Devices is a leading provider of high-performance...
This federal contract award is a $98,981.40 firm-fixed-price purchase order to Molecular Devices LLC, a division of Danaher Corporation, by the National Institute on Drug Abuse (NIDA). The award is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, and has received numerous prime contract awards...
This purchase order awards Molecular Devices LLC $293,764 to upgrade a Molecular Devices ImageXpress System for the National Center for Advancing Translational Sciences at the National Institutes of Health. The solicitation sought proposals for a high-performance 7 line laser light source, asynchronous dispense software, installation, and operational training to support the system. As the sole anticipated awardee and brand name equipment provider, Molecular Devices will deliver the requested...
This firm-fixed-price purchase order for $41,597.00 was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the delivery of a SpectraMax iD5 Standard Multimode Microplate Detection Platform, a specialized laboratory instrument used in life science research and drug discovery. Molecular Devices LLC is a manufacturer of high-performance...
This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Molecular Devices LLC for the provision of an ImageXpress Micro Confocal High Content Screening System. The $586,048.77 contract, which does not have a set-aside designation, has an ultimate completion date of May 15, 2017. Molecular Devices LLC, a division of Danaher Corporation, is a leading provider of bioanalytical measurement...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Molecular Devices LLC, a subsidiary of Danaher Corporation, for the delivery of an ISOCYTE SL-488 single laser instrument with a 488nm laser. The contract, valued at $167,000.00, does not have a set-aside designation. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development,...
Molecular Devices LLC was awarded a $38,056 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The award is to provide a GXP software bundle package, additional user licenses, annual maintenance and technical support, and installation services to upgrade three Molecular Devices readers currently used by the Vaccine Immunology Program at the Vaccine Research Center facility in...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC. The contract has a ceiling value of $10,061.98 and a period of performance through April 9, 2012. The award is for the procurement of Molecular Devices' bioanalytical laboratory instruments, equipment, and related services. Molecular Devices LLC is a subsidiary of the Danaher Corporation, a global...
This is a $249,827.18 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the supply of a QPIX Microbial Colony Picker, a specialized laboratory instrument used in life sciences research and drug discovery. Molecular Devices LLC, the prime contractor, is a leading provider of...

Molecular Devices LLC was awarded a $248,578.40 firm fixed price purchase order contract by the National Institutes of Health's National Institute on Drug Abuse to provide an OCTET RED384 High-Throughput Bio-Layer Interferometry (BLI) system and associated products and services. The award is in response to a solicitation from the National Center for Advancing Translational Sciences seeking an automated colony picker for high-throughput laboratory automation, including the BLI system, additional picking and streaking heads, on-site installation and training. Delivery is required within 16 weeks to the National Center for Advancing Translational Sciences in Rockville, Maryland. No set-aside designation was used for this contract.

Generated 2/22/24, 9:28 AM